Answers are grounded in this paper and cite their sources.
Peroxiredoxins (Prxs) are cysteine-based peroxide-reducing enzymes that have been extensively studied over the past two decades. The reduction of the Prx disulfide form is dependent on electron donating enzymes to shift the Prx back into a catalytically active state. However, this reaction is poorly understood and reductant enzymes for this reaction to reduce the Prx disulfide bond have received little attention. Prxs from the bacterium Xanthomonas campestris (XcPrxQ) were used to assess how reductants affect Prx turnover by identifying potential electron transfer interactions between Prxs and reductants, Glutaredoxins (Grxs) and Thioredoxins (Trxs). To examine potential interactions between PrxQ and reducing proteins, we used PrxQ, Grx, and Trx mutants to determine the effect of specific cysteines in each of the proteins. Mutant and wildtype proteins were expressed in E. coli and purified using anion-exchange and gel filtration chromatography and purity was verified by SDS-PAGE. The results clarified the role of the two cysteines in PrxQ, C48 and C84, which are thought to participate in the reduction reaction of hydrogen peroxide. They also show Trx and Grx proteins from the same bacterium are possible reductants for Prx turnover, as reactions with PrxQ have produced complex formation at a larger molecular weight, suggesting the reductant binding to PrxQ and reducing its disulfide bond. This study is significant because it reveals potential binding interactions between reductants and Prxs that regulate Prx turnover into a catalytically active state, allowing the enzyme to break down peroxide and prevent oxidative damage, as well as highlighting Trxs in bacteria as a potential drug target due to their regulation of hydrogen peroxide levels in pathogenic strains.
No takes yet. Share an insight, caveat, or question.
Kreinces Jason (2020) studied this question.
Synapse has enriched 4 related papers. Consider them for comparative context: